ONESOURCE SPECIALTY PHARMA
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Cashflow Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹-22 Cr | ₹-390 Cr | ₹-799 Cr |
| Adjustment | ₹285 Cr | ₹288 Cr | ₹605 Cr |
| Changes In working Capital | ₹-303 Cr | ₹-6.66 Cr | ₹19 Cr |
| Cash Flow after changes in Working Capital | ₹-40 Cr | ₹-109 Cr | ₹-176 Cr |
| Cash Flow from Operating Activities | ₹-47 Cr | ₹-109 Cr | ₹-165 Cr |
| Cash Flow from Investing Activities | ₹-300 Cr | ₹506 Cr | ₹-66 Cr |
| Cash Flow from Financing Activities | ₹417 Cr | ₹-384 Cr | ₹118 Cr |
| Net Cash Inflow / Outflow | ₹70 Cr | ₹13 Cr | ₹-112 Cr |
| Opening Cash & Cash Equivalents | ₹22 Cr | ₹9.41 Cr | ₹121 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹92 Cr | ₹22 Cr | ₹9.41 Cr |
Compare Cashflow Statement of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹17,889.6 Cr | 1.5% | 5.1% | -1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 1.5% |
5.1% |
-1% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses